Noesys Data Selected to Present Its Corporate Capabilities at TMTI Partnership Symposium

Cary, NC, April 24, 2010 --(PR.com)-- Noesys Data will present Artios™, its integrated “whole animal” database for model development and therapeutic research and its Data Services for reducing and formatting large physiological data sets for statistical analysis to the TMTI Performers.

Atrios™ the first to market whole animal database for animal model development, infectious disease research, and therapeutic intervention development has been developed with leading BSL 3 and BLS 4 laboratories, including a number of TMTI Performers conducting infectious disease research programs. Artios stores and analyzes physiologic data critical to model development and efficacy or safety studies and incorporates diverse data such as biomarker assay data, image data, analytical assay data, blood chemistry, clinical observations, and virtually any other data that is relevant to a therapeutic development project into an integrated database. The development of the whole animal database improves data utilization, speeds data analysis and provides decision support capabilities to shorten the time required to develop a new therapeutic for a biological threat. Artios is designed as a collaborative environment where researchers can import, analyze, and share data with others in remote laboratories, locations and institutions.

Noesys Data’s VP of Marketing, Mark Vander Hoff, commented; “It is quite an honor to be selected as one of seventeen vendors to present our capabilities to the TMTI Performers. We believe that Artios offers the Performers a significant advancement in data storage and analysis. The Artios platform was developed in direct response to customers who develop animal models for infectious diseases such as Anthrax, Hemorrhagic Fever, and Ebola and their need to incorporate diverse data such as biomarker levels, image analysis, and clinical observations into the physiologic data they record in their protocols.

The resulting integrated database provides a complete disease profile and documents efficacy and safety of therapeutic or protective interventions at the whole animal, organ system, cellular, and biochemical levels. This is a major advancement for the researcher. Previously researchers would spend large amounts of time trying to correlate external data collected in studies into the physiologic data sets and perform the required statistics and graphic to look for significant changes. With Artios, the data is incorporated into a single platform making data mining, graphing, analysis, and reporting streamlined. This decreases the time required to make decisions and speed promising therapeutics or interventions to market.”

Noesys Data also provides Data Services to researchers using its domain expertise in large physiological data sets, such as those generated in telemetry based animal models, to reduce the data into experiments, studies, and programs and format them for statistical analysis. The company also offers services to perform the required statistical analysis and independent third party reports for research performers. Vander Hoff commented further; “It is quite natural for researchers to want to analyze their own data. However, the nature and the sheer volume of data generated in a telemetry based studies is very different than anything they are used to dealing with. We have clients that decided to analyze their own data in their first studies only to find that it took them numerous cycles and many extra weeks of time to get the data properly formatted for the appropriate statistical analysis. Furthermore, each submission cycle added cost to their research study. They have selected Noesys Data for their data reduction and formatting needs for subsequent experiments.”

###